At PCC 2026, pharma attendees heard that companies need to balance automation with human oversight while navigating evolving expectations around transparency, risk, and ethical implementation.
Just minutes into the opening of the 2026 Pharmaceutical Compliance Congress in McLean, VA, conference chairperson Lisa LeCointe-Cephas announced: “I know it’s early, so I’m not going to make you do an ice breaker. Instead, I propose we all play a drinking game.”
Not exactly what you expect to
This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.
